1. Home
  2. ZLAB vs MDU Comparison

ZLAB vs MDU Comparison

Compare ZLAB & MDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • MDU
  • Stock Information
  • Founded
  • ZLAB 2013
  • MDU 1924
  • Country
  • ZLAB China
  • MDU United States
  • Employees
  • ZLAB N/A
  • MDU N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • MDU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • ZLAB Health Care
  • MDU Industrials
  • Exchange
  • ZLAB Nasdaq
  • MDU Nasdaq
  • Market Cap
  • ZLAB 3.5B
  • MDU 3.4B
  • IPO Year
  • ZLAB 2017
  • MDU N/A
  • Fundamental
  • Price
  • ZLAB $29.25
  • MDU $17.56
  • Analyst Decision
  • ZLAB Buy
  • MDU Strong Buy
  • Analyst Count
  • ZLAB 4
  • MDU 3
  • Target Price
  • ZLAB $47.37
  • MDU $21.67
  • AVG Volume (30 Days)
  • ZLAB 1.4M
  • MDU 1.2M
  • Earning Date
  • ZLAB 05-08-2025
  • MDU 05-08-2025
  • Dividend Yield
  • ZLAB N/A
  • MDU 2.58%
  • EPS Growth
  • ZLAB N/A
  • MDU N/A
  • EPS
  • ZLAB N/A
  • MDU 1.37
  • Revenue
  • ZLAB $398,988,000.00
  • MDU $1,757,978,000.00
  • Revenue This Year
  • ZLAB $44.43
  • MDU $10.58
  • Revenue Next Year
  • ZLAB $48.68
  • MDU $3.70
  • P/E Ratio
  • ZLAB N/A
  • MDU $12.92
  • Revenue Growth
  • ZLAB 49.59
  • MDU N/A
  • 52 Week Low
  • ZLAB $15.65
  • MDU $13.23
  • 52 Week High
  • ZLAB $39.77
  • MDU $20.39
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 38.00
  • MDU 63.22
  • Support Level
  • ZLAB $30.96
  • MDU $17.33
  • Resistance Level
  • ZLAB $32.02
  • MDU $17.56
  • Average True Range (ATR)
  • ZLAB 1.14
  • MDU 0.33
  • MACD
  • ZLAB -0.27
  • MDU 0.09
  • Stochastic Oscillator
  • ZLAB 4.87
  • MDU 81.93

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About MDU MDU Resources Group Inc. (Holding Company)

MDU Resources Group Inc operates in three business segments, which include the electric segment, which generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming; The natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington; The pipeline segment provides natural gas transportation and underground storage services through a regulated pipeline system in the Rocky Mountain and northern Great Plains regions of the United States.

Share on Social Networks: